Abstract:Receptor interacting protein 3 (RIP3) is a protein kinase essential for TNF-induced necroptosis. Phosphorylation on Ser-227 in human RIP3 (hRIP3) is required for its interaction with human mixed lineage kinase domain-like (MLKL) in the necrosome, a signaling complex induced by TNF stimulation. RIP1 and RIP3 mediate necrosome aggregation leading to the formation of amyloid-like signaling complexes. We found that TNF induces Thr-231 and Ser-232 phosphorylation in mouse RIP3 (mRIP3) and this phosphorylation is required for mRIP3 to interact with mMLKL. Ser-232 in mRIP3 corresponds to Ser-227 in hRIP3, whereas Thr-231 is not conserved in hRIP3. Although the RIP3-MLKL interaction is required for necroptosis in both human and mouse cells, hRIP3 does not interact with mMLKL and mRIP3 cannot bind to hMLKL. The species specificity of the RIP3-MLKL interaction is primarily determined by the sequence differences in the phosphorylation sites and the flanking sequence around the phosphorylation sites in hRIP3 and mRIP3. It appears that the RIP3-MLKL interaction has been selected as an evolutionarily conserved mechanism in mediating necroptosis signaling despite that differing structural and mechanistic bases for this interaction emerged simultaneously in different organisms. In addition, we further revealed that the interaction of RIP3 with MLKL prevented massive abnormal RIP3 aggregation, and therefore should be crucial for formation of the amyloid signaling complex of necrosomes. We also found that the interaction between RIP3 and MLKL is required for the translocation of necrosomes to mitochondria-associated membranes. Our data demonstrate the importance of the RIP3-MLKL interaction in the formation of functional necrosomes and suggest that translocation of necrosomes to mitochondria-associated membranes is essential for necroptosis signaling.

The E3 Ubiquitin Ligase Itch Couples Jnk Activation to Tnf Alpha-Induced Cell Death by Inducing C-Flipl Turnover

A five-year itch in TNF-alpha cytotoxicity: the time factor determines JNK action.

Linear Ubiquitination of Cflip Induced by LUBAC Contributes to TNFα-induced Apoptosis

Jun Turnover is Controlled Through JNK-Dependent Phosphorylation of the E3 Ligase Itch

Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α

Regulation of Linear Ubiquitin Chain Assembly Complex by Caspase-Mediated Cleavage of Rnf31

Regulation of Innate Immune Responses by Receptor Interacting Protein Kinases (172.43)

TNF-α Induces Two Distinct Caspase-8 Activation Pathways

TBK1 and IKKε prevent TNF-induced cell death by RIPK1 phosphorylation

Linear Ubiquitination of RIPK1 on Lys612 Regulates Systemic Inflammation via Preventing Cell Death.

Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO.

Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling.

K63-linked Ubiquitination Regulates RIPK1 Kinase Activity to Prevent Cell Death During Embryogenesis and Inflammation

Negative Regulation of the E3 Ubiquitin Ligase Itch Via Fyn-Mediated Tyrosine Phosphorylation

Genetic Delineation of the Pathways Mediated by Bid and JNK in Tumor Necrosis Factor-α-induced Liver Injury in Adult and Embryonic Mice*

TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members

TNF Is Partially Required for Cell-Death-Triggered Skin Inflammation upon Acute Loss of cFLIP

Ubiquitination of RIP is Required for Tumor Necrosis Factor Α-Induced NF-κB Activation

Selective activation of the c-Jun N-terminal kinase (JNK) pathway fails to elicit Bax activation or apoptosis unless the phosphoinositide 3′-kinase (PI3K) pathway is inhibited

Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNFα-mediated apoptosis

Restoration of NF-kappaB Activation by Tumor Necrosis Factor Alpha Receptor Complex-Targeted MEKK3 in Receptor-Interacting Protein-Deficient Cells.